Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form

Market Reports

Looking back on 2018 and making predictions for 2019

As the global pharmaceutical industry transitions from the knowns of 2018 into the unknowns of 2019, Dr Kevin Robinson caught up with some of the key players in the market to assess the year that was and the 12 months to come in terms of upcoming trends and developments

Serialisation is not enough

A global technology leader in supply chain security, Systech’s revolutionary solution provides authentic, safe and connected products throughout the pharmaceutical supply chain. Dr Kevin Robinson recently caught up with CEO Ara Ohanian to find out more

Preparing PIs for post EU-FMD success

Ian Haynes of Excellis Europe explains how the company’s unique approach to enabling collaboration between parallel importers is helping to simplify the transition to serialisation post EU-FMD

Eliminating the time thieves

Comprehensive scientific process engineering (CSPE) cuts delivery times and accelerates the commissioning of pharmaceutical systems. Dr Kevin Robinson spoke to Optima Pharma’s Gerhard Breu to find out more

Formulating for success with ODTs

An ageing global population, consumer demand for greater convenience and the need to improve patient compliance are driving the development of new platforms for orally disintegrating dosage forms

Choosing effective granulation strategies for effervescent formulations

Effervescent tablets and instant drinks are attractive dosage forms for healthcare companies looking to meet the needs of modern patients and consumers

FMD: clarification for wholesalers, distributors and logistics partners

Christian Taylor, Serialisation Business Consultant at Zetes, clears up some of the key pain points when it comes to the practical application of the Falsified Medicines Directive (FMD)

Serialisation and data connectivity: Part II

The new wrinkle in your supply chain, <a href='https://www.manufacturingchemist.com/news/article_page/Serialisation_and_data_connectivity_Part_I/147850'>click here to read part I</a>

Serialisation and data connectivity: Part I

The new wrinkle in your supply chain

A grandmaster’s approach to successful tableting

Tableting is a fundamental unit operation in the production of pharmaceutical oral solid dosage forms. Despite its long history of use and the development of innovations such as extended dwell times, unique technologies that independently and simultaneously measure and control both tablet weight and hardness, and a weight control system that provides increased sensitivity at lower forces, production problems still occur. Here, Dr Harald Stahl, Group Director, Application and Strategy Management, GEA, provides some troubleshooting tips from an unlikely source: the chess board

Discover, learn and connect at Lab Innovations!

Experience the latest developments at the UK’s only event dedicated to the laboratory industry

Pharmacovigilance in the hands of patients

Angharad Baldwin caught up with Dr Andrew Rut, founder of MyMeds&Me, at FutureLink 2018 to talk about what software as a service means to the pharmaceutical industry and the patient ... and whether there’s such a thing as too much data

ATP detection: The balance between precision and speed

Adenosine triphosphate (ATP) is an indicator molecule for the presence of biological residues used in food production. Burcu Yordem, 3M Food Safety, explains its role in an effective hygiene monitoring programme

Making a difference in pharma contract manufacturing

With a plant near Basel, Switzerland, and a heritage of more than 40 years, contract service provider Legacy Pharmaceuticals understands the value of flexibility and experience when producing parenteral and semisolid drugs. Dr Kevin Robinson spoke to Mike Danzi, Chief Executive Officer, to find out more

Continuously driving pharmaceutical manufacturing efficiencies

Continuous manufacturing has long been accepted by a host of manufacturing industries from food and beverage to oil and gas, where it ensures the delivery of a consistent and continuous quality of product

Health experts reveal 10 most important medicines in NHS history

Antipsychotics, breast cancer drug, oral contraceptives and MMR vaccine make the top 10

Brexit trade bill: Not yet

The UK has decided it will continue to be involved with the European Medicines Agency (EMA) after Brexit. Paul Brooks, Executive Director at the Regulatory Affairs Professionals Society (RAPS) asks what does this mean for the pharmaceutical industry and patients after 2020?

Maintenance across borders

Here, Dave Friar, International Operations Director at Boulting, international engineering solutions provider, considers what you should do when preparing to hand over maintenance control on an overseas project

Treating chronic wounds with live biotherapeutics

Angharad Baldwin talks to Evelina Vågesjö, CEO, and Peter Frank, Drug Development Manager, of Swedish biologics company, Ilya Pharma, about using live bacteria to treat chronic wounds

Isolator sterility put to the test

Sterility testing must be carried out under strict aseptic conditions. Stacey Orley, Wickham Laboratories, describes the process to ensure products and devices are contaminant-free

A new way of buying and selling APIs, additives, vitamins and excipients

Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and nutritional ingredients

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge potential applications. Angharad Baldwin interviews Professor Vipul Bansal, lead researcher, to find out more

Six months and counting

With 6 months to go until the DSCSA serialisation enforcement deadline kicks in, <i>Manufacturing Chemist</i> caught up with some leading lights in the industry to find out how companies were shaping up ahead of November to mark the occasion

Invisible benefits

SCHOTT enhances its iQ platform with the introduction of the new syriQ BioPure glass syringe for sensitive drugs
  • Previous
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • Next

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Overcoming the hurdles of strategic market expansion Ramprasad Kaparaboyena, Regulatory Affairs Manager and QP for Pharmacovigilance at Gaelic Laboratories, discusses how to overcome the challenges of expanding your pharma market into new global regions
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Reimagining biosimilars: faster access, stronger supply, sustainable healthcare Outdated development models, uneven adoption and policy barriers are holding Europe back. Dr Kevin Robinson (KSR) spoke to Matt Erick (ME), Head of Advanced Markets at Biocon Biologics (pictured), to discover how the industry can close the biosimilars void and unlock billions in savings
  3. Reading and understanding vendor-supplied tablet drawings Understanding the tablet drawings supplied by tooling vendors is a meaningful way to learn more about your product, reports John Norman, Technical Service Representative, Natoli Engineering Company
  4. Peak identification by LC/MS: Automation versus analyst High pressure liquid chromatography/mass spectrometry (LC/MS) is an important technique that facilitates the correct and accurate identification of impurities in pharmaceutical products and intermediates
  5. Freeze drying ADCs: points to consider for industrial applications As antibody-drug conjugates gain momentum in the pharmaceutical industry, manufacturers are increasingly looking to implement safe and effective process trains to produce them. Lyophilisation experts at GEA Pharma & Healthcare assess some of the most critical challenges and how to overcome them

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.